Publications by authors named "Andrew Lockhart"

Claim this Profile
M
Mechanisms of adaptive interlimb coordination to sudden ground loss: a neuromusculoskeletal modeling study.
Kota Shinohara, Yuichi Ambe, Yongi Kim, Fu Mano, Shravan Tata Ramalingasetty, Andrew B Lockhart

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Academia in the throes of faceless bureaucracy.
Jonathan Pansieri, David Menassa, Sandy Figiel, Marco Pisa, Andrew Lockhart

Brain· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reorganization of spinal neural connectivity following recovery after thoracic spinal cord injury: insights from computational modelling.
Natalia A Shevtsova, Andrew B Lockhart, Ilya A Rybak, David S K Magnuson, Simon M Danner

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel selective glucocorticoid receptor modulator GRM-01 demonstrates dissociation of anti-inflammatory effects from adverse effects on glucose and bone metabolism.
Florian Jakob, Stephanie Hennen, Michael Gautrois, Feras Khalil, Andrew Lockhart

Front Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for vessel-associated extracellular matrix proteins in multiple sclerosis pathology.
Marco Pisa, Joseph L Watson, Jonathan I Spencer, Guy Niblett, Yasamin Mahjoub, Andrew Lockhart

Brain Pathol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
POLR3A-related disorders: expanding the clinical phenotype.
Mary Clare McKenna, Antoinette O'Connor, Andrew Lockhart, Petya Bogdanova-Mihaylova, Francesca Brett

J Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional contribution of vascular dysfunction in white matter dementia: clinical and neuropathological insights.
Jonathan Pansieri, Gina Hadley, Andrew Lockhart, Marco Pisa, Gabriele C DeLuca

Front Neurol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain biopsy in neurological disease of unknown etiology: A single-center 12-year retrospective analysis.
Andrew Lockhart, Josephine Heffernan, Ann Kennedy, Andrea Walsh, Ciara Heeney

Clin Neuropathol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic neurologic syndromes with multiple neural autoantibodies: A report of two cases.
Andrew Lockhart, Peter Boers

J Neuroimmunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BK polyomavirus associated progressive multifocal leukoencephalopathy in a person living with HIV.
Brendan O'Kelly, Amy Keane, Emma Devitt, Andrew Lockhart, Deirdre O'Rourke

Brain Behav Immun Health· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rash developing after cessation of Daclizumab for relapsing remitting MS; a case series.
Andrew Lockhart, Brian Kirby, Christopher McGuigan

Mult Scler Relat Disord· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New versus old: Implications of evolving diagnostic criteria for relapsing-remitting multiple sclerosis.
Nuala McNicholas, Andrew Lockhart, Siew M Yap, Karen O'Connell, Niall Tubridy

Mult Scler· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of vascular disease in dementia: what does industry want to know?
Paul B Wren, Derek Hill, Andrew Lockhart

Clin Sci (Lond)· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A (Lp-PLA) Inhibitor [F]GSK2647544 in Healthy Male Subjects.
Mickael Huiban, Christopher Coello, Kai Wu, Yanmei Xu, Yvonne Lewis, Andrew Lockhart

Mol Imaging Biol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the safety, pharmacokinetics, pharmacodynamics, and drug-drug interaction potential of a selective Lp-PLA2 inhibitor (GSK2647544) in healthy volunteers
.
Kai Wu, Jianfeng Xu, Regan Fong, Xiaozhou Yao, Yanmei Xu, Andrew Lockhart

Int J Clin Pharmacol Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease.
Gareth Maher-Edwards, Jeni De'Ath, Carly Barnett, Arseniy Lavrov, Andrew Lockhart

Alzheimers Dement (N Y)· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?
Emilio Merlo Pich, Andreas Jeromin, Giovanni B Frisoni, Derek Hill, Andrew Lockhart

Alzheimers Res Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholestenoic acids regulate motor neuron survival via liver X receptors.
Spyridon Theofilopoulos, William J Griffiths, Peter J Crick, Shanzheng Yang, Anna Meljon, Andrew Lockhart

J Clin Invest· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study.
Julie E Davidson, Andrew Lockhart, Leslie Amos, Heide A Stirnadel-Farrant, Vincent Mooser

Alzheimers Res Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, Maria Bjerke, Marinus A Blankenstein, Andrew Lockhart

Biomark Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain?
Michael Ogundare, Spyridon Theofilopoulos, Andrew Lockhart, Leslie J Hall, Ernest Arenas

J Biol Chem· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.
Paul W Thompson, Liang Ye, Jennifer L Morgenstern, Lucia Sue, Thomas G Beach, Andrew Lockhart

J Neurochem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the amyloid beta-peptide in vivo--caveat emptor.
Paul W Thompson, Andrew Lockhart

Drug Discov Today· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovering oxysterols in plasma: a window on the metabolome.
William J Griffiths, Martin Hornshaw, Gary Woffendin, Sharon F Baker, Andrew Lockhart

J Proteome Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain.
Liang Ye, Ana Velasco, Graham Fraser, Thomas G Beach, Lucia Sue, Andrew Lockhart

J Neurochem· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis